The Genomics Core Facility at the Icahn School of Medicine at Mount Sinai currently operates a diverse world-class next generation sequencing platform (NGS) suite directed by Robert Sebra, Ph.D. alongside Associate Director, Kristin Beaumont, Ph.D. (single cell molecular biology & sequencing), and Assistant Director, Mike Beaumont, Ph.D (physiology and functional validation) who guide sequencing/molecular and single cell technologies. Since 2013, the team has successfully published over 250 collaborative high-impact publications and has played an ample role in submitting dozens of grants which have been funded across various disease foci including cancer, inherited disease, structural variation, infectious disease and innovative technology development.
The Center for Advanced Genomic Technology facility's NGS suite includes platforms from Illumina (2 NovaSeq 6000s, 2 NextSeq 550s, 2 MiSeqs, 2 MiniSeqs, 1 HiScan), PacBio (1 Revio, 1 Sequel IIe), IonTorrent (3 Ion S5XL instruments, 3 Ion Chefs), 10X Genomics (1 Chromium X instrument, 2 Chromium iX, 2 CytAssists, 1 Xenium), MissionBio (Tapestri instruments), and Element (1 AVITI/24 platform). The combination of various sequencing equipment facilitates a broader range of clinical and scientific applications through the generation of flexible and robust data across a variety of genetic loci of varying complexity. Beyond bulk DNA and RNA sequencing methods, the lab also has equipment and expertise centered on single cell and low-input characterization using 1 Element system, 4 Chromium 10X Genomics instrument, and 1 MissionBio Tapestri system. With this equipment, single cells can be isolated from viable tissue and processed by a variety of molecular methods for sequencing purposes, post amplification, at capacity of tens of thousands of cells per day from individual samples. Current example projects include characterization of single cells derived from various patient tumor biopsies across primary and metastatic sites to better understand tumor heterogeneity, as well as characterization of single cells isolated from various regions of brain, heart, and other tissues for discovery and characterization of niche functional populations. The team is comprised of 23 staff and faculty harbored in a >4500 sq ft innovation laboratory inclusive of instrumentation, wet bench, and cell biology space, including a cell biology space with a BSL2 lab and the basic science lab.
Computational Resources
High Performance Computing (HPC) cluster: A central High-Performance Computing (HPC) facility with 40-Petabyte storage capacity called “Minerva” is available for secondary and tertiary data analysis. The Minerva cluster consists of 25,584 Intel Platinum processors with 70 teraflop peak speed and 408 NVIDIA GPUs, interconnected through a 400 Gb/s NDR Fat-Tree InfiniBand network. Each compute node is equipped with at least 512 GB of memory, with 33 1.5-TB high-memory nodes. The hardware accessible for analysis is optimized for parallel jobs that are CPU-bound such as NGS read mapping, as well as parallel jobs such as Bayesian network reconstruction that are memory-bound. In addition, the high-speed InfiniBand interconnects enable jobs requiring substantial shared memory, such as all-by-all comparisons of splice-form specific RNA-seq results to generate isoform-specific co-expression networks. Minerva is connected to Globus, a secure and high-performance data transfer service, for fast data transfers to external sites. Access to ISMMS computational resources is restricted by firewalls and external access is provided through secure shell/ftp with two-factor authentication.
The software and programming environments offered on Minerva are cutting edge, including community standards such as Linux and MPI. The cluster runs resource managers and schedulers to balance job workload, optimized to process as many jobs as possible for the highest overall machine utilization, job throughput, and job success rate. Minerva is operated with over 95% uptime, using scalable and reproducible configuration management techniques. Long-term archival storage is provided by a high-capacity Tivoli Storage Manager (TSM) system and protects against data loss. One copy of the tapes is kept off-site (New Jersey) and one stays onsite at Mount Sinai. All data on the tapes are encrypted. In accordance with Sinai policy, tapes are kept for at least six years.
The Minerva file system provides extensive data capacity (approximately 32 PB of storage overall) for high performance storing and accessing research data, based on IBM Spectrum Scale (formerly known as GPFS). The Center for Advanced Genomic Technology has a dedicated allocation of 1480 TB for various projects in parallel.
Project Submission Form
Our submission form includes our most up-to-date selection of assays, as well as contact information for all teams. Please read the Center policies on the right side and check for the correct section on the left before submitting your request. Sample submission information, including shipping address, will be provided after your project is approved by the team.